Read Next
International
Report: 25% of Belgian euthanasia patients in 2025 were not terminally ill
Cassy Cooke
·Spotlight Articles
Abortion Pill·By Carole Novielli
'It's a dream': Group promotes prototype over-the-counter abortion pill
Advancing New Standards in Reproductive Health (ANSIRH) researchers recently rolled out a prototype of what an over-the-counter abortion pill might look like, calling it "a dream that could one day be reality."
ANSIRH has introduced a prototype of MiMi, an over-the-counter abortion pill regimen of mifepristone and misoprostol, which it is now promoting even though it is not yet a legal reality.
They created the mock-up to "help folks envision a world where medication abortion is accessible, over-the-counter, and available without a prescription," saying, "we can dream of a future where MiMi is available to everyone at an affordable price."
The safety protocols placed on the abortion pill when women died after taking it have been eroded over the years, without any studies proving the changes would be safe for women. Obviously, the abortion pill is deadly to preborn children, meaning it cannot truly be "safe."
Even before the FDA has completed its safety review of the abortion pill, ANSIRH is pushing to have the drug regimen on grocery store shelves.
The "mock up," called "MiMi" (which stands for abortion drugs mifepristone and misoprostol) was "created by researchers at UC San Francisco (UCSF) ANSIRH to help folks envision a world where medication abortion is accessible, over-the-counter, and available without a prescription," ANSIRH wrote on Facebook.
"While we can’t get abortion pills off the shelf YET, we can dream of a future where MiMi is available to everyone at an affordable price," ANSIRH wrote on their Facebook page.
ANSIRH also wrote on BlueSky:
Meet MiMi! A conceptual design for a future over-the-counter medication abortion kit containing instructions, abortion pills, and a pregnancy test.
MiMi is not yet available—but it’s a dream that could one day be reality.
This is not yet a reality, which ANSIRH acknowledged on its newly-created website MiMi4All.com, referring to the possibility of OTC abortion drugs as "a dream that could one day be reality."
According to the website, MiMi4All.com:
MiMi is a conceptual design for a future over-the-counter medication abortion kit containing instructions, abortion pills, and a pregnancy test. MiMi is not yet available—but it’s a dream that could one day be reality.
MiMi would include two medicines, mifepristone and misoprostol, for medication abortion. Currently, abortion pills are available through in-person clinics, telehealth services with mail delivery, and community support networks, depending on state laws. But the MiMi design represents a way that medication abortion could be available in the future on the shelf of a pharmacy or grocery store without a prescription.
The MiMi design illustrates the simplicity and safety of medication abortion. In addition to the information on the box, there is a leaflet inside the box with clear instructions about how to use MiMi. The experience is designed to help people understand each step clearly, with simple language and supportive information.
The leaflet contains instructions that some certified abortion pill prescribers fail to heed:
"Do not use MiMi if you are more than 10 weeks (70 days) pregnant"
"Have ever had, or currently have, a pregnancy outside the uterus (ectopic pregnancy)"
The MiMi website tells viewers to "Spread the news on MiMi... by using the hashtag #MiMi4All" and urges viewers to "Keep abortion bans out of medicine cabinets and mailboxes by joining the #MifeInAll50 campaign."
The MiMi4all website also published a video from pro-abortion Advocates for Youth (AFY) using young people to promote the prototype as "cute."
Texas-based abortion group Jane's Due Process is also promoting it on their social media:
The prototype OTC package and drug facts label (DFL) were reviewed in a survey to see the reaction, as Live Action News previously documented.
Abortionist Daniel Grossman of ANSIRH told KUOW:
If they were interested and eligible to participate in the study, they looked at a box that is kind of like a prototype packaging for what an over-the-counter medication abortion package might look like.
Grossman has been a sponsor of abortion pill clinical trials claiming the drug is safe, and he regularly promotes use of the drug outside the FDA-approved REMS safety requirements, including OTC and advanced provision of the drug without confirmation of pregnancy.
The document linked to mimi-pills.com ("MiMi" for the two drugs: mifepristone and misoprostol) but did not link to FDA safety data or the 2023 mifepristone label which includes a black box warning of serious bleeding, infection, and possible sepsis, among other dangers.
MiMi's website claimed "3 in 100 users... will need an in-clinic procedure..." contradicting the abortion pill manufacturer's website:
About 2 to 7 out of 100 women taking Mifeprex will need a surgical procedure because the pregnancy did not completely pass from the uterus or to stop bleeding.
The prototype packaging also failed to advise participants that the FDA's REMS safety system requires prescribers of the drug (not end users) to handle complications/failures, or refer to someone who can.
The MiMipills.com original leaflet predictably said nothing about the embryo or fetus, merely referring to "the pregnancy," an obfuscation often used by the abortion industry.
It advises women to "monitor their symptoms," fails to emphasize risks of sepsis or hemorrhage (claiming only that bleeding and fever are "rare"), claims there is no age restriction on using the pills, and suggests that RH factor testing and ultrasounds (to determine gestational age even possible ectopics) are generally unnecessary.
The abortion pill was approved by the FDA in 2000, and since then, those behind the approval and those working to fund expansions of the drug have been attempting to put the drug in the hands of as many pregnant women as possible.
Under the Clinton Administration, Big Abortion got the drug approved for in-person dispensing with a required follow-up visit, which was later removed.
What Big Abortion failed to see coming were the dangers.
In 2001, the first death from the drug was reported. The news hit just after the 9/11 attack on the U.S., and as one person who was behind clinical trials callously explained, the attack "saved mifepristone" by overshadowing the abortion pill death.
Gynuity founder by Beverly Winikoff, M.D., M.P.H then told two Columbia University journalists, ''Well, it was one death versus three thousand."
Winikoff was previously employed by the Population Council, which brought the abortion pill into the U.S. and set up DANCO as the manufacturer. Winikoff had a previous contract with DANCO Laboratories, has been aggressively working to expand abortion and has also been sponsoring U.S. abortion pill clinical trials via TelAbortion.
After several reported deaths associated with the abortion pill, the drug was then placed under FDA's REMS safety system to monitor adverse events.
By 2016, under the Obama Administration, Big Abortion was able to convince FDA to expand its use to ten weeks. The abortion industry then made their next move by trotting out a "no-test" abortion pill protocol in 2020, during the COVID-19 pandemic, something they had in their bag of tricks prior to the pandemic.
By 2023, the Biden Administration had removed the in-person requirement for dispensing the drug and opened the flood gates for mail order and pharmacy dispensing. They were on course for their all-out goal of over-the-counter use, until the large pushback they received from pro-life OBGYNS with Alliance for Hippocratic Medicine (AHM), who filed a lawsuit to stop the madness.
Further lawsuits were filed, both by states seeking to protect preborn children and some seeking to expand abortion. Then, under the Trump Administration, despite approving a second generic abortion pill drug, the FDA promised a new safety review — which terrified Big Abortion.
During the subsequent litigation, Big Abortion went completely off the rails, prescribing the drug well into the second and even third trimesters, selling the abortion pill "just in case" or in "advance" of a pregnancy, and even deceptively as a "missed period pill." They also began their pivot to the one-drug protocol of misoprostol only.
Now, even before the safety review or any updates therein have come out, Big Abortion is planning its next move: getting abortion pills on store shelves.
ANSIRH was founded by abortionist Felicia Stewart, a 'mentor' of current ANSIRH director Tracey Weitz.
ANSIRH, which publishes the TEACH Early Abortion Training Curriculum, is a "program within the UCSF Bixby Center for Global Reproductive Health and is a part of UCSF's Department of Obstetrics, Gynecology & Reproductive Sciences," the website notes.
UCSF has been funded by the David and Lucile Packard Foundation, which invested $14.2 million to help with the start-up of abortion pill manufacturer Danco Laboratories.
The next question becomes, Who will profit the most if or when the OTC abortion pill "dream" comes true?
The drug makers will, of course, but definitely not the innocent preborn lives these drugs kill every single day.
Live Action News is pro-life news and commentary from a pro-life perspective.
Our work is possible because of our donors. Please consider giving to further our work of changing hearts and minds on issues of life and human dignity.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Cassy Cooke
·
Abortion Pill
Carole Novielli
·
Abortion Pill
Carole Novielli
·
Abortion Pill
Bridget Sielicki
·
Abortion Pill
Newsroom
·Abortion Pill
Carole Novielli
·Abortion Pill
Carole Novielli
·
Investigative
Carole Novielli
·
Abortion Pill
Carole Novielli
·Abortion Pill·By Carole Novielli
'It's a dream': Group promotes prototype over-the-counter abortion pill
Advancing New Standards in Reproductive Health (ANSIRH) researchers recently rolled out a prototype of what an over-the-counter abortion pill might look like, calling it "a dream that could one day be reality."
ANSIRH has introduced a prototype of MiMi, an over-the-counter abortion pill regimen of mifepristone and misoprostol, which it is now promoting even though it is not yet a legal reality.
They created the mock-up to "help folks envision a world where medication abortion is accessible, over-the-counter, and available without a prescription," saying, "we can dream of a future where MiMi is available to everyone at an affordable price."
The safety protocols placed on the abortion pill when women died after taking it have been eroded over the years, without any studies proving the changes would be safe for women. Obviously, the abortion pill is deadly to preborn children, meaning it cannot truly be "safe."
Even before the FDA has completed its safety review of the abortion pill, ANSIRH is pushing to have the drug regimen on grocery store shelves.
The "mock up," called "MiMi" (which stands for abortion drugs mifepristone and misoprostol) was "created by researchers at UC San Francisco (UCSF) ANSIRH to help folks envision a world where medication abortion is accessible, over-the-counter, and available without a prescription," ANSIRH wrote on Facebook.
"While we can’t get abortion pills off the shelf YET, we can dream of a future where MiMi is available to everyone at an affordable price," ANSIRH wrote on their Facebook page.
ANSIRH also wrote on BlueSky:
Meet MiMi! A conceptual design for a future over-the-counter medication abortion kit containing instructions, abortion pills, and a pregnancy test.
MiMi is not yet available—but it’s a dream that could one day be reality.
This is not yet a reality, which ANSIRH acknowledged on its newly-created website MiMi4All.com, referring to the possibility of OTC abortion drugs as "a dream that could one day be reality."
According to the website, MiMi4All.com:
MiMi is a conceptual design for a future over-the-counter medication abortion kit containing instructions, abortion pills, and a pregnancy test. MiMi is not yet available—but it’s a dream that could one day be reality.
MiMi would include two medicines, mifepristone and misoprostol, for medication abortion. Currently, abortion pills are available through in-person clinics, telehealth services with mail delivery, and community support networks, depending on state laws. But the MiMi design represents a way that medication abortion could be available in the future on the shelf of a pharmacy or grocery store without a prescription.
The MiMi design illustrates the simplicity and safety of medication abortion. In addition to the information on the box, there is a leaflet inside the box with clear instructions about how to use MiMi. The experience is designed to help people understand each step clearly, with simple language and supportive information.
The leaflet contains instructions that some certified abortion pill prescribers fail to heed:
"Do not use MiMi if you are more than 10 weeks (70 days) pregnant"
"Have ever had, or currently have, a pregnancy outside the uterus (ectopic pregnancy)"
The MiMi website tells viewers to "Spread the news on MiMi... by using the hashtag #MiMi4All" and urges viewers to "Keep abortion bans out of medicine cabinets and mailboxes by joining the #MifeInAll50 campaign."
The MiMi4all website also published a video from pro-abortion Advocates for Youth (AFY) using young people to promote the prototype as "cute."
Texas-based abortion group Jane's Due Process is also promoting it on their social media:
The prototype OTC package and drug facts label (DFL) were reviewed in a survey to see the reaction, as Live Action News previously documented.
Abortionist Daniel Grossman of ANSIRH told KUOW:
If they were interested and eligible to participate in the study, they looked at a box that is kind of like a prototype packaging for what an over-the-counter medication abortion package might look like.
Grossman has been a sponsor of abortion pill clinical trials claiming the drug is safe, and he regularly promotes use of the drug outside the FDA-approved REMS safety requirements, including OTC and advanced provision of the drug without confirmation of pregnancy.
The document linked to mimi-pills.com ("MiMi" for the two drugs: mifepristone and misoprostol) but did not link to FDA safety data or the 2023 mifepristone label which includes a black box warning of serious bleeding, infection, and possible sepsis, among other dangers.
MiMi's website claimed "3 in 100 users... will need an in-clinic procedure..." contradicting the abortion pill manufacturer's website:
About 2 to 7 out of 100 women taking Mifeprex will need a surgical procedure because the pregnancy did not completely pass from the uterus or to stop bleeding.
The prototype packaging also failed to advise participants that the FDA's REMS safety system requires prescribers of the drug (not end users) to handle complications/failures, or refer to someone who can.
The MiMipills.com original leaflet predictably said nothing about the embryo or fetus, merely referring to "the pregnancy," an obfuscation often used by the abortion industry.
It advises women to "monitor their symptoms," fails to emphasize risks of sepsis or hemorrhage (claiming only that bleeding and fever are "rare"), claims there is no age restriction on using the pills, and suggests that RH factor testing and ultrasounds (to determine gestational age even possible ectopics) are generally unnecessary.
The abortion pill was approved by the FDA in 2000, and since then, those behind the approval and those working to fund expansions of the drug have been attempting to put the drug in the hands of as many pregnant women as possible.
Under the Clinton Administration, Big Abortion got the drug approved for in-person dispensing with a required follow-up visit, which was later removed.
What Big Abortion failed to see coming were the dangers.
In 2001, the first death from the drug was reported. The news hit just after the 9/11 attack on the U.S., and as one person who was behind clinical trials callously explained, the attack "saved mifepristone" by overshadowing the abortion pill death.
Gynuity founder by Beverly Winikoff, M.D., M.P.H then told two Columbia University journalists, ''Well, it was one death versus three thousand."
Winikoff was previously employed by the Population Council, which brought the abortion pill into the U.S. and set up DANCO as the manufacturer. Winikoff had a previous contract with DANCO Laboratories, has been aggressively working to expand abortion and has also been sponsoring U.S. abortion pill clinical trials via TelAbortion.
After several reported deaths associated with the abortion pill, the drug was then placed under FDA's REMS safety system to monitor adverse events.
By 2016, under the Obama Administration, Big Abortion was able to convince FDA to expand its use to ten weeks. The abortion industry then made their next move by trotting out a "no-test" abortion pill protocol in 2020, during the COVID-19 pandemic, something they had in their bag of tricks prior to the pandemic.
By 2023, the Biden Administration had removed the in-person requirement for dispensing the drug and opened the flood gates for mail order and pharmacy dispensing. They were on course for their all-out goal of over-the-counter use, until the large pushback they received from pro-life OBGYNS with Alliance for Hippocratic Medicine (AHM), who filed a lawsuit to stop the madness.
Further lawsuits were filed, both by states seeking to protect preborn children and some seeking to expand abortion. Then, under the Trump Administration, despite approving a second generic abortion pill drug, the FDA promised a new safety review — which terrified Big Abortion.
During the subsequent litigation, Big Abortion went completely off the rails, prescribing the drug well into the second and even third trimesters, selling the abortion pill "just in case" or in "advance" of a pregnancy, and even deceptively as a "missed period pill." They also began their pivot to the one-drug protocol of misoprostol only.
Now, even before the safety review or any updates therein have come out, Big Abortion is planning its next move: getting abortion pills on store shelves.
ANSIRH was founded by abortionist Felicia Stewart, a 'mentor' of current ANSIRH director Tracey Weitz.
ANSIRH, which publishes the TEACH Early Abortion Training Curriculum, is a "program within the UCSF Bixby Center for Global Reproductive Health and is a part of UCSF's Department of Obstetrics, Gynecology & Reproductive Sciences," the website notes.
UCSF has been funded by the David and Lucile Packard Foundation, which invested $14.2 million to help with the start-up of abortion pill manufacturer Danco Laboratories.
The next question becomes, Who will profit the most if or when the OTC abortion pill "dream" comes true?
The drug makers will, of course, but definitely not the innocent preborn lives these drugs kill every single day.
Live Action News is pro-life news and commentary from a pro-life perspective.
Our work is possible because of our donors. Please consider giving to further our work of changing hearts and minds on issues of life and human dignity.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Cassy Cooke
·Abortion Pill
Carole Novielli
·Abortion Pill
Carole Novielli
·Abortion Pill
Bridget Sielicki
·Abortion Pill
Newsroom
·Abortion Pill
Carole Novielli
·Abortion Pill
Carole Novielli
·Investigative
Carole Novielli
·Abortion Pill
Carole Novielli
·